Deutsche Bank Ag\ Ligand Pharmaceuticals Inc Call Options Transaction History

Deutsche Bank Ag\

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 11, 2022	SELL	$127.69 - $165.85 $8,938 - $11,609	-70 Reduced 46.67%	80 $12,000
Q3 2021 Nov 04, 2021	BUY	$102.33 - $144.73 $12,893 - $18,235	126 Added 525.0%	150 $21,000
Q3 2020 Nov 12, 2020	SELL	$89.56 - $126.72 $20,419 - $28,892	-228 Reduced 90.48%	24 $2,000
Q3 2019 Nov 14, 2019	SELL	$86.25 - $120.16 $1,380 - $1,922	-16 Reduced 5.97%	252 $25,000
Q1 2019 May 15, 2019	BUY	$105.93 - $142.47 $23,728 - $31,913	224 Added 509.09%	268 $33,000
Q2 2018 Aug 14, 2018	SELL	$150.77 - $207.98 $55,784 - $76,952	-370 Reduced 89.37%	44 $9,000
Q1 2018 May 15, 2018	BUY	$138.63 - $182.62 $26,894 - $35,428	194 Added 88.18%	414 $68,000
Q4 2017 Feb 14, 2018	BUY	$128.36 - $147.04 $28,239 - $32,348	220	220 $30,000

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.